Why 90% of clinical drug development fails and how to improve it?

Sun, Duxin, Gao, Wei, Hu, Hongxiang, Zhou, Simon·2022·Acta Pharmaceutica Sinica B
DOI 10.1016/j.apsb.2022.02.002

Cited by (1,000)

Items 701–800 of 1,000

  1. Multiorgan-on-a-chip for cancer drug pharmacokinetics-pharmacodynamics (PK-PD) modeling and simulations
    Abdurehman Eshete Mohammed, Filiz Kurucaovalı, Devrim Pesen‐Okvur · 2024 · Journal of Pharmacokinetics and Pharmacodynamics
  2. Trends in drug repurposing for chronic hepatitis-B infection: Bibliometric-based approach 1990-2024
    Lalu Muhammad Irham, Danang Prasetyaning Amukti, Wirawan Adikusuma, Dilpreet Singh, Rockie Chong, Satriya Pranata, Sabiah Khairi · 2024 · BIO Web of Conferences
  3. KNU-DTI: KNowledge United Drug-Target Interaction prediction
    Ryong Heo, Dahyeon Lee, Byung Ju Kim, Sangmin Seo, Sanghyun Park, Chihyun Park · 2025 · Computers in Biology and Medicine
  4. Enhancing throughput and robustness of the fibroblast to myofibroblast transition assay
    Elisabeth Bäck, Jessica Bjärkby, Leire Escudero‐Ibarz, Stefan Tångefjord, Johan Jirholt, Mei Ding · 2025 · SLAS DISCOVERY
  5. The missing enzymes: a call to update pharmacological profiling practices for better drug safety assessment
    Maciag, Monika, Karamyan, Vardan T. · 2025 · Journal of Medicinal Chemistry
  6. Revolutionizing Drug Discovery: A Systematic Review of AI and Machine Learning Application
    Ismatul Jannat Chowdhury, Md. Shorif Hossan, Mohammed Ziauddin Khan, Tanvir Zobair Mahboob, Yadab Sutradhar, Md. Anwar Hossain, Md Masum · 2025 · International Conference on Self Sustainable Artificial Intelligence Systems (ICSSAS)
  7. Organoid Technologies for SARS-CoV-2 Research
    Khiry Sutton, Timothy S. Leach, Vikram Surendran, Phillip W. Clapp, Sean V. Murphy · 2022 · Current Stem Cell Reports
  8. Structure and dynamic simulation-based interactions of benzenoids, pyrroles and organooxygen compounds for effective targeting of GPX4 in ischemic stroke
    Namrata Sangwan, Jitender Singh, Arushi Chauhan, Ajay Prakash, Krishan Lal KHANDUJA, Bikash Medhi, Pramod Avti · 2022 · Journal of Biomolecular Structure and Dynamics
  9. On effects that do occur versus effects that can be made to occur
    Markus Bräuer, Kevin R. Kennedy · 2023 · Frontiers in Social Psychology
  10. MolCAP: Molecular Chemical reActivity Pretraining and prompted-finetuning enhanced molecular representation learning
    Yu Wang, Jingjie Zhang, Junru Jin, Leyi Wei · 2023 · Computers in Biology and Medicine
  11. Predicting routes of phase I and II metabolism based on quantum mechanics and machine learning
    Mario Öeren, Peter A. Hunt, Charlotte E. Wharrick, Hamed Tabatabaei Ghomi, Matthew Segall · 2023 · Xenobiotica
  12. Molecular Simulation in Drug Design: An Overview of Molecular Dynamics Methods
    Fernando Daniel Prieto-Martínez, Yelzyn Galván-Ciprés, Blanca Colín-Lozano · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
  13. Identification of active compounds as novel dipeptidyl peptidase-4 inhibitors through machine learning and structure-based molecular docking simulations
    Shahid M. Ali, Sibhghatulla Shaikh, Khurshid Ahmad, Inho Choi · 2023 · Journal of Biomolecular Structure and Dynamics
  14. Goal-directed molecule generation with fine-tuning by policy gradient
    Chunli Sha, Fei Zhu · 2024 · Expert Systems with Applications
  15. Engineering CREB‐activated promoters for adenosine‐induced gene expression
    J.R. Cox, Andrea Fox, C. Lenahan, Liza Pivnik, Matthew Manion, John Blazeck · 2024 · Biotechnology Journal
  16. Identification of a potent PCNA‐p15‐interaction inhibitor by autodisplay‐based peptide library screening
    Sarah Hardebeck, Natalie Jácobo Goebbels, Caroline Michalski, Sebastian Schreiber, Joachim Jose · 2024 · Microbial Biotechnology
  17. Comparisons of successful and failed Phase III trials of drugs and biologicals tested for mitigation of oral mucositis in patients being treated with radiotherapy with or without concomitant chemotherapy for cancers of the head and neck
    Lang Liang, Stephen T. Sonis · 2024 · Drug Development Research
  18. Computational Modeling to Identify Drugs Targeting Metastatic Castration-Resistant Prostate Cancer Characterized by Heightened Glycolysis
    Mei‐Chi Su, Adam M. Lee, Weijie Zhang, Danielle Maeser, Robert F. Gruener, Yibin Deng, R. Stephanie Huang · 2024 · Pharmaceuticals
  19. Target repositioning using multi-layer networks and machine learning: The case of prostate cancer
    Milan Picard, Marie‐Pier Scott‐Boyer, Antoine Bodein, Mickaël Leclercq, Julien Prunier, Olivier Périn, Arnaud Droit · 2024 · Computational and Structural Biotechnology Journal
  20. Strategies for Redesigning Withdrawn Drugs to Enhance Therapeutic Efficacy and Safety: A Review
    Chirag Patel, Adeeba Shakeel, Raghvendra Mall, Khadija M. Alawi, Ivan V. Ozerov, Alex A. Zhavoronkov, Filippo Castiglione · 2025 · Wiley Interdisciplinary Reviews Computational Molecular Science
  21. Incorporation of an Isohexide Subunit Improves the Drug-like Properties of Bioactive Compounds
    Achyutharao Sidduri, Mark Dresel, Spencer Knapp · 2023 · ACS Medicinal Chemistry Letters
  22. EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening
    Ambra Cappelletto, Edoardo Alfì, Nina Volf, Thi Van Anh Vu, Francesca Bortolotti, Giulio Ciucci, Simone Vodret, Marco Fantuz, Martina Perin, Andrea Colliva et al. · 2024 · Journal of Experimental & Clinical Cancer Research
  23. An overview to drug repurposing
    Khushal Khambhati, Abdulrahman H. Alessa, Vijai Singh · 2024 · Progress in molecular biology and translational science
  24. Foundations of the Theory of Innovation Failure: Theoretical Structure and Evidence
    Mario Coccia · 2023 · SSRN Electronic Journal
  25. Integration of Dendrimer‐Based Delivery Technologies with Computational Pharmaceutics and Their Potential in the Era of Nanomedicine
    Karnaker R. Tupally, Prasenjit Seal, Preeti Madhuri Pandey, Rink‐Jan Lohman, Sean Campbell Smith, Defang Ouyang, Harendra S. Parekh · 2024
  26. On-target toxicity limits the efficacy of CDK11 inhibition against cancers with 1p36 deletions
    Linda Julian, Lisa Crozier, Devon A. Lukow, Sanat Mishra, Aditi Swamy, Ryan A. Hagenson, Peter C. Sennhenn, Erin L. Sausville, Brianna E. Mendelson, Claudio Chuaqui et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  27. Membrane-active peptides for anticancer therapies
    Charles H. Chen · 2024 · Progress in molecular biology and translational science
  28. Scaling factors to inform in vitro-in vivo extrapolation from preclinical and livestock animals: state of the field and recommendations for development of missing data
    A. Zimmer, A. Collier · 2025 · Drug metabolism reviews (Softcover ed.)
  29. Miniaturized High-Throughput Amorphous Solid Dispersion Screening via Picoliter Volume 2D-Inkjet Printing of Formulation Microarrays
    Georgios Papakostas, Philip Corner, Andrew L. Hook, Stephanie C. Brookes, Jonathan Booth, J. Burley, James Francis McCabe · 2025 · Molecular Pharmaceutics
  30. Efficacy of Endophytic Bacterium Serratia marcescens B.SB 1.1 associated with Sea Fern (Acrostichum aureum L.) as an Antidiabetic Agent
    Tetty Marta Linda, Dinda Putri Maisyaroh, Azizul Berlyansah, Balqis Juanne Tasliyah, Erwina Juliantari, Delita Zul, Bernadeta Leni Fibriarti, Asih Rahayu Ajeng Agesti, Yuli Haryani · 2025 · Journal of Microbiology and Biotechnology
  31. Attenuation of 6‑OHDA-Induced Neurotoxicity by 1,2,3-Triazole-Based Sulfonamides through SIRT1 Activity
    Papitcha Jongwachirachai, Ratchanok Pingaew, Veda Prachayasittikul, Waralee Ruankham, Setthawut Apiraksattayakul, Wilasinee Suwanjang, Tanawut Tantimongcolwat, Virapong Prachayasittikul, Supaluk Prachayasittikul, Kamonrat Phopin · 2025 · ACS Omega
  32. Antimalarial Drug Repurposing of Epirubicin and Pelitinib in Combination with Artemether and Lumefantrine
    Douglas Ongeri Ochora, Reagan M. Mogire, Bernard M. Murithi, Farid Abdi, Erick Nyakundi Ondari, Rael Jepkogei Masai, Edwin W. Mwakio, Agnes Cheruyiot, Abiy Yenesew, Hoseah Miima Akala · 2025 · Pharmaceuticals
  33. Harnessing hibernation: Unlocking nature's secrets for advances in healthy aging, critical care, and space exploration
    Kelly L. Drew, Vadim B. Fedorov, Khrystyne N. Duddleston, Øivind Tøien · 2025 · Annals of the New York Academy of Sciences
  34. Hybrid 2-Quinolone–1,2,3-triazole Compounds: Rational Design, In Silico Optimization, Synthesis, Characterization, and Antibacterial Evaluation
    Ayoub El‐Mrabet, Abderrahim Diane, Rachid Haloui, Hanae El Monfalouti, Ashwag S. Alanazi, Mohamed Hefnawy, Mohammed Mater Alanazi, Y. Kandri Rodi, Souad Elkhattabi, Ahmed Mazzah et al. · 2025 · Antibiotics
  35. Challenges of broad-spectrum antiviral drug discovery and development for emerging pathogens
    Holli‐Joi Martin, Jon-Michael T. Beasley, Enes Kelestemur, Zoe L. Sessions, Stephan Ludwig, Nathaniel J. Moorman, Ralph Steven Baric, Eugene N. Muratov, Alexander Tropsha · 2025 · Drug Discovery Today
  36. Oncology in the AI Era: Transforming Cancer Care Through Intelligent Diagnosis and Treatment
    Sonopant Ganapatrao Joshi, Husain K Nadaf, Mangesh Jabade, Shital Pimpalekar · 2025 · Springer eBooks
  37. In situ formation and culture of cell spheroids in a low-binding 3D-printed biochip
    Alexandre Martins, Sylvie Klieber, Charlotte Le Graët, Éric Leclerc, Cécile Legallais, Rachid Jellali · 2025 · Lab on a Chip
  38. GEODE: an in silico tool that translates in vitro to in vivo predictions of tuberculosis antibiotic combination efficacy
    Maral Budak, Mariana Pereira Moraes, Talia Greenstein, Pauline A Maiello, Henry Jacob Borish, Harris B. Chishti, Kara B. Kracinovsky, Mark Rodgers, Jaime A. Tomko, Philana Ling Lin et al. · 2025 · Frontiers in Pharmacology
  39. Cationic PPC liposomes with dual targeting modules for enhanced liver fibrosis therapy via the extracellular matrix barrier
    Ying Li, Yuanyuan Zhou, Lifang Wu, Quanyuan Gao, Wei Wang · 2025 · Biomaterials Science
  40. Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors
    Evangelos Mavridis, Dimitra Hadjipavlou‐Litina · 2025 · International Journal of Molecular Sciences
  41. High-throughput screening and meta-analysis for lead compounds in antimalarial drug discovery
    Nguyen Van Truong, Seok-Won Na, Ji Hoon Park, Tuyet-Kha Nguyen, Nguyen Sy Thau, Thi-Thanh Hang Chu, Bazgha Sanaullah, Ch Venkataramaiah, Jin‐Hee Han, Sunghun Na et al. · 2025 · Malaria Journal
  42. MolP-PC: a multi-view fusion and multi-task learning framework for drug ADMET property prediction
    Sishu Li, Jing Fan, Haiyang He, Ruifeng Zhou, Jun Liao · 2025 · Chinese Journal of Natural Medicines
  43. UK Biobank: Transforming drug discovery and precision medicine
    Jelena Bešević, Saredo Said, Réka Nagy, Yalda Jamshidi, Christopher D. Whelan, Lauren Carson, Martin K. Rutter, Adam J. Lewandowski, Mark Effingham, Rory Collins et al. · 2025 · British Journal of Pharmacology
  44. Ferrocene tethered imidazoline NHC silver complex [FeMImiMeNHC-Ag] Catalyzed synthesis, anticancer activity, apoptosis, cell cycle arrest and in silico studies of new benzoxazoles
    Amruta Pore, Vikas D. Kadu, Raghunath B. Bhosale, Shashikant V. Bhandari, Yash Shimpi, Trupti Bansode, Nisha Nerlekar, Padma Babulal Dandge, Gajanan S. Rashinkar, Prakash A. Bansode · 2025 · Journal of Molecular Structure
  45. Non-oncology orphan drug development: Productivity and probability of success
    Samantha Parker, Jida El Hajjar, Anneliene Hechtelt Jonker, Susan Rebecca Kahn, Persefoni Kritikou, Christina Kyriakopoulou, Anthony R. Haight · 2025 · Drug Discovery Today
  46. Liposomal systems for targeted drug delivery to hair follicles in the topical treatment of androgenetic alopecia
    Sonam M. Gandhi, Sambhavi Swarn, Uttam Ashok More, Vipin Saini, Devesh U. Kapoor, Bhupendra Gopalbhai Prajapati · 2025 · Journal of Drug Delivery Science and Technology
  47. Development of machine learning-based multi-task quantitative structure–activity relationship models for predicting toxicities in six human organ systems
    Pei-Yu Wu, Wei‐Chun Chou, Venkata Nithin Kamineni, Chi-Yun Chen, Jui‐Hua Hsieh, Chris D. Vulpe, Zhoumeng Lin · 2025 · Computational Toxicology
  48. Humanized liver mouse models in preclinical drug development: current status, translation challenges and emerging technologies
    Xumiao Zhang, Lu Lu, Wei Xiao, Yuanbin Song · 2026 · Drug Discovery Today
  49. Artificial intelligence and machine learning driven nanorobotics for targeted brain delivery: Redefining blood-brain barrier navigation
    Suraj Kumar, Rishabha Malviya, Sathvik Belagodu Sridhar, Tarun Wadhwa, Javedh Shareef · 2026 · Journal of Neuroscience Methods
  50. Genetic evidence that FGF21 signaling reduces problematic alcohol use and alcohol-related liver disease
    Daniel B. Rosoff, Josephin Wagner, Tyler Perlstein, Joshua Reitz, Jeesun Jung, Hanna L. Blaney, Ahmed M. Gharib, Christine Hsu, Theo Heller, Christopher Koh et al. · 2026 · Journal of Hepatology
  51. Query Matters: How Selection Strategies Influence Active Learning in Drug Discovery
    Huw Williams, Stephen D. Pickett, Andrew W. Baxter, David Scott Palmer · 2026 · Journal of Chemical Information and Modeling
  52. Unifying the odyssey: artificial intelligence for rare disease diagnosis and therapy
    Mai‐Lan Ho, Marinka Žitnik, Ronen Azachi, Sanjay Basu, Pranav Rajpurkar, Richard Sidlow · 2026 · Health and Technology
  53. Machine-learning-enabled modeling of pharmacokinetics and pharmacodynamics
    Yorgos M. Psarellis, Nikhil Pillai, Saroj Dhakal, Panteleimon D. Mavroudis · 2026 · Drug Discovery Today
  54. Eliminating Unnecessary Animal Testing
    Tracy Beth Høeg, Steven Kozlowski, Haleh Saber, Martin A. Makary · 2026 · JAMA
  55. A Review of Recent Advances in the Anticancer Mechanisms of Activity of Novel Thiazoles and 4-Thiazolidinones/Thiazolidinediones (2021–2025)
    Rostyslav Dudchak, Magdalena Podolak, Anna Bielawska, Krzysztof Bielawski, Roman Lesyk · 2026 · Molecules
  56. Human organoids: Fit for drug discovery?
    Annika Wittich, Kim Krieg, Philip M. Gribbon, Jakob Johannes Metzger, Alessandro Prigione, Ole Pleß · 2026 · Stem Cell Reports
  57. Therapeutic Applications of Natural Products in Biomedicine and Pharmacotherapy
    Ashok Kumar Sah, Sakshi Patel, Dr.R .Pranesh Kumar, Prem Shankar Mishra, Rakhi Mishra, Абдулхаков Ихтиёр Умарович, Rabab H. Elshaikh, Shagun Agarwal, Ashwani Bhardwaj, Ranjay Kumar Choudhary et al. · 2026 · Life
  58. Harnessing Artificial Intelligence for the Detection and Management of Colorectal Cancer Treatment
    Michael Jacob, Ruhananhad P. Reddy, Ricardo Isaiah Garcia, Aananya P. Reddy, Sachi Khemka, Aryan Kia Roghani, Vasanthkumar Pattoor, Ujala Sehar, P. Hemachandra Reddy · 2024 · Cancer Prevention Research
  59. In Silico Approach for Assessment of the Anti‐Tumor Potential of Cannabinoid Compounds by Targeting Glucose‐6‐Phosphate Dehydrogenase Enzyme
    Cromwel Tepap Zemnou, Jaouad Anissi, Salim Bounou, Fernando Berton Zanchi · 2024 · Chemistry & Biodiversity
  60. Modern Drug Research and Its Impact on Pharmaceutical Industries
    Rajat Nath, Sibashish Kityania, Subrata Kumar Das, Deepa Nath, Jayanta Kumar Patra, Anupam Das Talukdar · 2024 · Interdisciplinary biotechnological advances
  61. Unveiling the potential anticancer activity of new dihydropyrimidines through dual inhibition of EGFR and TrkA: Design, synthesis, and in silico study
    Aya M Slly, Wafaa A Ewes, Waleed A. Bayoumi, Khalid B. Selim · 2024 · Bioorganic Chemistry
  62. Advancing 3D Engineered In Vitro Models for Heart Failure Research: Key Features and Considerations
    Elisa C. H. van Doorn, Jorik H. Amesz, Olivier Christiaan Manintveld, Natasja M. S. de Groot, Jeroen Essers, Su Ryon Shin, Yannick J.H.J. Taverne · 2024 · Bioengineering
  63. Real-time and regional analysis of the efficacy of anticancer drugs in a patient-derived intratumoral heterogeneous tumor microenvironment
    Ya‐Hui Lin, Chiao-Min Lin, Kee‐Ming Man, Chih‐Chiang Hung, Hsin-Ling Hsu, Yunching Chen, Hsuan‐Yu Mu, Tzu‐Hung Hsiao, Jen‐Huang Huang · 2025 · Lab on a Chip
  64. Panel discussions on the global regulatory acceptance and harmonisation of non-animal NAMs
    Lilas Courtot, Ellen Fritsche, Nina Hobi, Nicole Kleinstreuer, Robert Lee, Surat Parvatam, Merel J. Ritskes-Hoitinga, Clive S. Roper, Carl Westmoreland, Emeline Gougeon · 2025 · NAM journal.
  65. A Versatile Platform for Designing and Fabricating Multi-Material Perfusable 3D Microvasculatures
    Nathaniel Harris, Charles William Miller, Min Zou · 2025 · Micromachines
  66. Ex situ heart perfusion: A novel platform to test cardiovascular therapeutics in human hearts
    John Louca, Magnus Althage, Marco Öchsner, Aravinda Page, Joao Pedro Nunes, Catherine H. Wilson, Sanjay Sinha, Simon J. Messer, James Matt Bae, Mostin Hu et al. · 2025 · JHLT Open
  67. Longitudinal Proteomic Changes in HCT 116 Colon Cancer Spheroids During Growth
    Catherine B. Whitney, Nicole C. Beller, Brian D. Fries, Arbil Lopez, Amanda B. Hummon · 2025 · Journal of Proteome Research
  68. Genetic evidence informs the direction of therapeutic modulation in drug development
    Robert K. Chen, Áine Duffy, Joshua K. Park, David F. Stein, Avner Schlessinger, Yuval Itan, Benjamin Scott Glicksberg, Rory James Tinker, Daniel M. Jordan, Ghislain Rocheleau et al. · 2025 · npj Drug Discovery.
  69. Development of a Novel Tool To Demystify Drug Distribution at Tissue‐Blood Barriers
    Elizabeth A. Hughes, Rafal J. Zielinski, Ashley E. Ray, Waldemar Priebe, Eugene F. Douglass · 2023 · ChemBioChem
  70. Structure-property Relationships Reported for the New Drugs Approved in 2022
    Kihang Choi · 2023 · Mini-Reviews in Medicinal Chemistry
  71. Phase I Studies: Innovations and Issues
    Paul R. Beninger · 2024 · Clinical Therapeutics
  72. The importance of preclinical models in cholangiocarcinoma
    Owen McGreevy, Mohammed Bosakhar, Timothy M. Gilbert, Marc Quinn, Stephen William Fenwick, Hassan Malik, Christopher E. Goldring, Laura E. Randle · 2024 · European Journal of Surgical Oncology
  73. Marine Prostanoids with Cytotoxic Activity from Octocoral Clavularia spp.
    Ming-Ya Cheng, I-Chi Hsu, Shiying Huang, Ya-Ting Chuang, Tzi‐Yi Ke, Hsueh‐Wei Chang, Tian‐Huei Chu, Ching‐Yeu Chen, Yuan‐Bin Cheng · 2024 · Marine Drugs
  74. Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetes
    Jongmin Yoon, Don‐Gil Lee, H. J. Song, Dahae Hong, Ji Soo Park, Chang-Hee Hong, Kyung Mi An, Jung Woo Lee, Joon-Tae Park, Hongchul Yoon et al. · 2024 · Biomedicine & Pharmacotherapy
  75. Repurposing the Open Global Health Library for the discovery of novel Mpro destabilizers with scope as broad-spectrum antivirals
    Francisco Castillo, David Ramírez, María C. Ramos, Blanca Martínez-Arribas, Elisabeth Domingo-Contreras, Thomas Andrew Mackenzie, Carlos Peña-Varas, S. Lindemann, Fernando Montero, Fredderick Annang et al. · 2024 · Frontiers in Pharmacology
  76. Evolution of toxicity testing platforms from 2D to advanced 3D bioprinting for safety assessment of drugs
    Rohin Shyam, Rinni Singh, Mukul Bajpai, Arunkumar Palaniappan, Ramakrishnan Parthasarathi · 2024 · Bioprinting
  77. Identification of Anti-Tuberculosis Drugs Targeting DNA Gyrase A and Serine/Threonine Protein Kinase PknB: A Machine Learning-Assisted Drug-Repurposing Approach
    Dongwoo Lee, M. Islam, Sathishkumar Natarajan, D. Dudekula, Ho-Kweon Chung, Junhyung Park, Bermseok Oh · 2024 · Tropical Medicine and Infectious Disease
  78. Current Approaches and Strategies Applied in First‐in‐class Drug Discovery
    Idrees Mohammed, Someswar Rao Sagurthi · 2024 · ChemMedChem
  79. Harnessing the potential of human induced pluripotent stem cells, functional assays and machine learning for neurodevelopmental disorders
    Ziqin Yang, Nicole A. Teaney, Elizabeth D. Buttermore, Mustafa Şahin, Wardiya Afshar Saber · 2025 · Frontiers in Neuroscience
  80. Comprehensive evaluation of pure and hybrid collaborative filtering in drug repurposing
    Clémence Réda, Jill-Jênn Vie, Olaf Wolkenhauer A · 2025 · Scientific Reports
  81. Identification of a TNIK-CDK9 Axis as a Targetable Strategy for Platinum-Resistant Ovarian Cancer
    Noah Puleo, Harini Ram, Michele L. Dziubinski, Dylan Carvette, Jessica Teitel, Sreeja C. Sekhar, Karan Bedi, Aaron M. Robida, Michael M. Nakashima, Sadaf Farsinejad et al. · 2025 · Molecular Cancer Therapeutics
  82. Absorption of Toxicants from the Ocular Surface: Potential Applications in Toxicology
    Ivan Šoša, Manuela Perković, Ivanka Baniček Šoša, Petra Grubešić, Dijana Tomić Linšak, Ines Strenja-Linić · 2025 · Biomedicines
  83. Maternal transfer of anti-GAPDH IgG prevents neonatal infections caused by Staphylococcus aureus and group B Streptococcus
    Filipa Lemos, Marta Vieira, Ana Fidalgo, Liliana Curado, Cristiana Nogueira, Joana B. Nunes, Joana Mafra, Cátia Silva, Olga L. Caramelo, Maria do Céu Almeida et al. · 2025 · iScience
  84. Time for a paradigm shift in immunotherapy-based BCMA/CD3 bispecific drug development in multiple myeloma
    Xavier P Leleu, Arthur Bobin, André Herbelin, Jean‐Marc Gombert, S. Vincent Rajkumar · 2025 · Leukemia
  85. From Gene Networks to Therapeutics: A Causal Inference and Deep Learning Approach for Drug Discovery
    Sudhir K. Ghandikota, Anil Goud Jegga · 2025 · Pharmaceuticals
  86. From single-omics to interactomics: How can ligand-induced perturbations modulate single-cell phenotypes?
    Luiz Felipe Piochi, A.T. Gaspar, Nícia Rosário‐Ferreira, António J. Preto, Irina Sousa Moreira · 2022 · Advances in protein chemistry and structural biology
  87. Acridone Alkaloids: In-Silico Investigation Against SARS-CoV-2 Main Protease
    Ogunyemi Olajide Oderinlo, Chiamaka Gift Iwegbulam, Overcomer Abumonye Ekweli, Taye Temitope Alawode, Oluwatoba Emmanuel Oyeneyin · 2022 · Chemistry Africa
  88. Fast Methods for Drug Approval: Research Perspectives for Pandemic Preparedness
    Ahmad Yaman Abdin, Francesco De Pretis, Jürgen Landes · 2023 · International Journal of Environmental Research and Public Health
  89. Drug Discovery for Periodontitis Treatment Based on Big Data Mining, Systems Biology, and Deep Learning Methods
    Chun-Tse Wang, Bor‐Sen Chen · 2023 · SynBio
  90. Novel Phenylene Lipids That Are Positive Allosteric Modulators of Glycine Receptors and Inhibitors of Glycine Transporter 2
    Casey I. Gallagher, Zachary J. Frangos, Diba Sheipouri, Susan Shimmon, Meryem-Nur Duman, S. Jayakumar, Christopher L. Cioffi, Tristan Rawling, Robert J. Vandenberg · 2023 · ACS Chemical Neuroscience
  91. Silica nanoparticles for brain cancer
    Yuran Feng, Yuxue Cao, Ravi Singh, Taskeen Iqbal Janjua, Amirali Popat · 2023 · Expert Opinion on Drug Delivery
  92. Supply Chain Logistics and Business Ecosystems Needed for the Development of Natural Vaccines with Novel, Safer, and Noninvasive Delivery Mechanisms
    Dawson Dodds, John Warren Kindt, Christopher da Costa, Nazmul Kazi, Joseph T. Mahoney, S. Indu Rupassara · 2024 · Pharmaceutical science.
  93. Scoping Pleiotropy of CK2 in Musculoskeletal Disorders for a Novel Targeting Approach
    Venu Pandit, Kailey DeGeorge, Anja Nohe · 2024 · Kinases and Phosphatases
  94. Proteomic workflows for deep phenotypic profiling of 3D organotypic liver models
    Stefania Koutsilieri, Evgeniya Mickols, Ákos Végvári, Volker Martin Lauschke · 2024 · Biotechnology Journal
  95. Trends Innovations Challenges in Employing Interdisciplinary Approaches to Biomedical Sciences
    Moorthy Ganeshkumar, Shamini Ayyadhury, Elavazhagan Murugan · 2024 · Springer eBooks
  96. Proteolysis targeting chimera extracellular vesicles for therapeutic development treating triple negative breast cancer
    Nina Erwin, Umasankar De, Yufeng Xiao, Lei Wang, Chandra Kumar Maharjan, Xiaoshu Pan, Nikee Awasthee, Guangrong Zheng, Daiqing Liao, Weizhou Zhang et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Editorial: Opportunities and challenges in drug repurposing
    Ihosvany Camps, Stephan R. Künzel, Mario Schubert, Ramendra Kumar Singh · 2025 · Frontiers in Pharmacology
  98. Targeting STAT3, FOXO3a, and Pim‐1 kinase by FDA‐approved tyrosine kinase inhibitor–Radotinib: An in silico and in vitro approach
    Suryaa Manoharan, Aksayakeerthana Santhakumar, Ekambaram Perumal · 2024 · Archiv der Pharmazie
  99. Schiff Base Mediated Synthesis of Novel Imidazolidine‐4‐One Derivatives for Potential Antimicrobial and Anthelmintic Activities
    Naresh Babu Chilamakuru, Singirisetty Triveni, Anoop Bodapati, Sudha Divya Madhuri Kallam, Vinod Kumar Nelson, Punna Rao Suryadevara, T. Selvankumar · 2024 · Luminescence
  100. Large-Scale Compartmental Model-Based Study of Preclinical Pharmacokinetic Data and Its Impact on Compound Triaging in Drug Discovery
    Peter Zhiping Zhang, Jeanine E. Ballard, Facundo Esquivel Fagiani, Dustin M. Smith, Christopher R. Gibson, Xiang Yu · 2025 · Molecular Pharmaceutics